The atriopeptidase inhibitor (±)candoxatrilat reduces the clearance of atrial natriuretic factor in both intact and nephrectomized rats: evidence for an extrarenal site of action-Reference-Cited by-同舟云学术

The atriopeptidase inhibitor (±)candoxatrilat reduces the clearance of atrial natriuretic factor in both intact and nephrectomized rats: evidence for an extrarenal site of action

Published:1991-03 Issue:5 Volume:41 Page:841-844
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Barclay Paul L.,Bennett John A.,Samuels Gillian M.R.,Shepperson Nicholas B.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference22 articles.

1. The atrial natriuretic factor, its physiology and biochemistry;Genest;Rev Physiol Biochem Pharmacol,1989

2. Metabolic clearance rate and plasma half life of alpha human natriuretic peptide in man;Yandle;Life Sci,1986

3. The hydrolysis of alpha human atrial natriuretic peptide by pig kidney membranes is initiated by endopeptidase 24.11;Stephenson;Biochem J,1987

4. Identipcation of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney;Sonnenberg;Peptides,1988

5. Potentiation of the depressor responses to atrial natriuretic peptides in conscious SHR by an inhibitor of neutral endopeptidase;Seymour;J Cardiovasc Pharmacol,1989

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema;British Journal of Pharmacology;2008-03

2. The Therapeutic Potential of Candoxatril, a Neutral Endopeptidase Inhibitor, in Humans;Cardiovascular Drug Reviews;2006-06-07

3. Inhibition of Neutral Endopeptidase Causes Vasoconstriction of Human Resistance Vessels In Vivo;Circulation;1998-06-16

4. Characterization of neutral endopeptidase in vascular cells, modulation of vasoactive peptide levels;European Journal of Pharmacology;1998-03

5. Neutral endopeptidase inhibitors and the pulmonary circulation;General Pharmacology: The Vascular System;1996-06